This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Overactive Bladder: Adopting a Patient-Centered Approach to Improve Outcomes and Quality of Life

Overactive Bladder: Adopting a Patient-Centered Approach to Improve Outcomes and Quality of Life

Format

Expert Perspective

Time to Complete

1 hour

Released

May 22, 2017

Expires

May 21, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour
1.00 / CPD Credit

Accredited Provider



This activity is provided by Global Education Group.

Commercial Supporter

This activity is supported by an educational grant from Astellas.

Producer



Produced by Haymarket Medical Education (HME)

Program Description

Overactive bladder (OAB) affects more than 400 million people worldwide, and the number is growing. The condition often has a serious impact on patient quality of life; early recognition of the spectrum and impact of OAB is essential so that therapy can be individualized and initiated as quickly as possible. Available treatments for symptoms encompass both behavioral interventions and pharmacotherapy. Unfortunately, up to 40% of patients have inadequate relief of incontinence with pharmacotherapy, with high discontinuation rates and poor adherence reported for OAB medications.

In this CME activity, 4 international, renowned experts convene to discuss optimal approaches to the identification and treatment of OAB, taking into consideration potential variations in practice among the United States, Europe, and Asia. The panel will discuss practical methods for assessing OAB symptoms and ruling out other potential etiologies, initiating discussions about urinary health with patients who may be reluctant to do, and implementing evidence-based behavioral interventions. The benefits of drawback of the available pharmacotherapies for OAB will be described, as will recent clinical trial data on investigational combination therapy. The need for frequent follow-up, individualized treatment, and good patient-provider communication will be discussed in detail.

Intended Audience

Urologists, urogynecologists, obstetrician-gynecologists (ob-gyns), primary care clinicians, nurse practitioners (NPs), physician assistants (PAs), nurses, and other healthcare providers who treat patients with bladder dysfunction

Educational Objectives

After completing this activity, the participant should be better able to:

  • Evaluate and diagnose overactive bladder (OAB)
  • Utilize current therapeutic options for managing OAB, focusing on individualized therapy
  • Review emerging pharmacologic strategies for OAB management
  • Provide proper counseling and support to patients with OAB to increase their motivation for treatment-plan adherence

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Matt Rosenberg, MD (Chair)
Medical Director
Mid Michigan Health Centers
Department of Family Medicine
Allegiance Health Systems
Jackson, Michigan

Dr. Rosenberg is a consultant and stockholder for OPKD and serves on the Speakers’ Bureau for Astellas.

Professor Christopher Chapple, BSc, MD, FRCS (Urol), FEBU
Consultant Urological Surgeon, Royal Hallamshire Hospital
Honorary Professor, University of Sheffield
Visiting Professor, Sheffield Hallam University
Secretary General, European Association of Urology
Sheffield, UK

Dr. Chapple is a consultant for Allergan, Astellas, Medtronic, and Recordati. He also receives grant/research support from Allergan, Astellas, and Recordati and serves on the Speakers’ Bureau for Allergan and Astellas.

Professor Marcus Drake, BM, BCh, MA (Cantab), DM (Oxon)
Professor of Physiological Urology
Senior Lecturer
University of Bristol
Bristol, UK

Dr. Drake is a speaker for Allergan, Astellas, Ferring, and Pfizer and receives research support from Allergan, Astellas, and Ferring.

Kyu-Sung Lee, MD, PhD
Professor, Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine
General Director
Biomedical Engineering Research Center
Samsung Medical Center
South Korea

Dr. Lee is a consultant for and receives grant/research support from Astellas Asia-Pacific.

Publishing/Accreditor Staff Disclosures

Andrea Funk, Ashley Marostica, RN, MSN, and Karen Kaufman of Global Education Group have nothing to disclose in regard to commercial interests.

Susan Basilico, Angie Ladas, and Krista Sierra of Haymarket Medical Education have nothing to disclose in regard to commercial interests.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

Learning Credit(s)

Accreditation Statement

Suggested CPD credit for UK clinicians.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

There is no fee for this activity.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Astellas, Global Education Group, or Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a post-test score of 70% or better is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can then access at any time.

If you have any questions relating to the accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

If you have any questions relating to other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

myCME privacy policy

Global protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the customer’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue